SLIDESHOW: Top Buys By Top Brass: Insiders Place Big Bets

#23. Douglas S. Ingram Buys $2M of Sarepta Therapeutics, Inc. latest buy: 11/03/2023

During the last six months, Ingram bet big on SRPT:

Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. Co. is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy, Limb-girdle muscular dystrophies and other neuromuscular and central nervous system related disorders. Co.'s commercial product, EXONDYS 51® (eteplirsen) Injection is indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping.

SRPT — Key Stats (updated 9 hours, 11 minutes ago)

Name:  Sarepta Therapeutics Inc Website:  www.sarepta.com Sector:  Biotechnology Number of ETFs Holding SRPT:  34 (see which ones) Total Market Value Held by ETFs:  $1,209,066,067.68 Total Market Capitalization:  $11,532,000,000 % of Market Cap. Held by ETFs:  10.48%

Open the SRPT Videos Page (in a new window) »

Featured Slideshows

10 Energy Stocks You Can Buy Cheaper Than Insiders Did Cheap Energy Stocks Paying Dividends Cheap Oil Stocks Paying Dividends Warren Buffett Energy Stocks The Top 10 DividendRank'ed Stocks The DividendRank Top 25 The Top 10 DividendRank'ed DJIA Components The Top 10 DividendRank'ed Dow Transports Components The Top 10 DividendRank'ed Dow Utilities Components The Top 10 DividendRank'ed Nasdaq 100 Components 10 Stocks Going Ex-Dividend 10 Oversold Dividend Stocks 10 Stocks Where Yields Got More Juicy 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did Top Ranked Dividend Stocks With Insider Buying 10 ETFs With Stocks That Insiders Are Buying 25 Dividend Giants Widely Held By ETFs 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades Broker Darlings: Top 15 Analyst Picks of the Dow Top 25 Broker Analyst Picks of the S&P 500 Forgotten S&P 500 Giants: Analysts' Current Least Favorites Feel-Good Income: 25 Socially Responsible Dividend Stocks 10 Metals Stocks You Can Buy Cheaper Than Insiders Did 10 Oversold Metals Stocks 10 Must-Know High-Yield REITs 10 Top DividendRank'ed Financials 10 Top DividendRank'ed Metals Stocks 10 Oversold Energy Stocks 10 Top DividendRank'ed Energy Stocks 10 Top DividendRank'ed Utility Stocks 10 Stocks Crossing Below Book Value 10 Stocks Crossing Above Their 200 Day Moving Average 10 Stocks Crossing Below Their 200 Day Moving Average 10 Energy Stocks Crossing Above Their 200 DMA 10 Energy Stocks Crossing Below Their 200 DMA The 10 Biggest ETFs The 10 Best ETF Performers The 10 Worst ETF Performers 10 ETFs With Notable Inflows 10 ETFs With Notable Outflows Top 10 Analyst Rated Consumer Stocks Top 10 Analyst Rated Dividend Stocks Top 10 Analyst Rated Energy Stocks Top 10 Analyst Rated Financial Stocks Top 10 Analyst Rated Healthcare Stocks Top 10 Analyst Rated REIT Stocks Top 10 Analyst Rated Technology Stocks The Top 10 DividendRank'ed Canadian Stocks The DividendRank Canada Top 25 10 Canadian Stocks Going Ex-Dividend 10 Oversold Canadian Stocks 10 Canadian Stocks Where Yields Got More Juicy 10 Must-Know High-Yield Canadian Real Estate Stocks 10 Top DividendRank'ed Canadian Financials 10 Must-Know High-Yield Canadian Energy Stocks 10 Canadian Stocks Crossing Below Book Value 10 Canadian Stocks Crossing Above Their 200 Day Moving Avg 10 Canadian Stocks Crossing Below Their 200 Day Moving Avg Stock market game

Featured News Links

• Press releases from ACCESSWIRE  • If This 1 Thing Changes, This 6.5% Dividend Will Be a Raging Buy  • These 9% Dividends Are Usually “Millionaires Only.” No More.  • How to Buy Yields up to 12% for Pennies on the Dollar  • These 8% Dividends Are Due for a “Delayed Reaction” Surge

Top Buys By Top Brass: Insiders Place Big Bets | Market News Video | Copyright © 2008 - 2024, All Rights Reserved